V. Friand

526 total citations
9 papers, 455 citations indexed

About

V. Friand is a scholar working on Cell Biology, Oncology and Molecular Biology. According to data from OpenAlex, V. Friand has authored 9 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cell Biology, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in V. Friand's work include Chemokine receptors and signaling (6 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Cell Adhesion Molecules Research (4 papers). V. Friand is often cited by papers focused on Chemokine receptors and signaling (6 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Cell Adhesion Molecules Research (4 papers). V. Friand collaborates with scholars based in France, United States and Japan. V. Friand's co-authors include Pascale Zimmermann, Guido David, Liliane Gattegno, Nathalie Charnaux, Angéla Sutton, Michel Kraemer, Odile Sainte‐Catherine, Line Saffar, Oualid Haddad and Marianne Ziol and has published in prestigious journals such as Free Radical Biology and Medicine, Journal of Hepatology and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

V. Friand

9 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Friand France	8	263	144	142	116	93	9	455
Bernadette C. Victor United States	6	291 1.1×	133 0.9×	79 0.6×	61 0.5×	129 1.4×	6	466
Sander P.J. Joosten Netherlands	10	288 1.1×	236 1.6×	95 0.7×	53 0.5×	101 1.1×	12	481
Jakub Kryczka Poland	13	192 0.7×	97 0.7×	68 0.5×	43 0.4×	104 1.1×	23	381
Mark Wasner Germany	8	390 1.5×	213 1.5×	65 0.5×	44 0.4×	81 0.9×	8	485
Jeannette Bourguignon France	15	425 1.6×	110 0.8×	184 1.3×	42 0.4×	102 1.1×	25	604
Megumi Funakoshi Japan	7	239 0.9×	92 0.6×	103 0.7×	84 0.7×	111 1.2×	7	416
Megumi Miyamoto Japan	6	162 0.6×	125 0.9×	22 0.2×	151 1.3×	36 0.4×	10	381
Timo Korb Germany	5	113 0.4×	219 1.5×	106 0.7×	46 0.4×	56 0.6×	5	359
Keli Ma China	11	279 1.1×	31 0.2×	45 0.3×	94 0.8×	90 1.0×	23	395

Countries citing papers authored by V. Friand

Since Specialization

Citations

This map shows the geographic impact of V. Friand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Friand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Friand more than expected).

Fields of papers citing papers by V. Friand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Friand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Friand. The network helps show where V. Friand may publish in the future.

Co-authorship network of co-authors of V. Friand

This figure shows the co-authorship network connecting the top 25 collaborators of V. Friand. A scholar is included among the top collaborators of V. Friand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Friand. V. Friand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Friand, V., Guido David, & Pascale Zimmermann. (2015). Syntenin and syndecan in the biogenesis of exosomes. Biology of the Cell. 107(10). 331–341. 149 indexed citations

Saito, Naoaki, Hanna Hlawaty, V. Friand, et al.. (2014). RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway. Biology Open. 3(10). 995–1004. 10 indexed citations

Friand, V., Oualid Haddad, Dulce Papy-García, et al.. (2009). Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells. Glycobiology. 19(12). 1511–1524. 33 indexed citations

Friand, V., Oualid Haddad, Hanna Hlawaty, et al.. (2009). Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1790(10). 1314–1326. 46 indexed citations

Brulé, Séverine, V. Friand, Angéla Sutton, et al.. (2009). Glycosaminoglycans and syndecan-4 are involved in SDF-1/CXCL12-mediated invasion of human epitheloid carcinoma HeLa cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1790(12). 1643–1650. 27 indexed citations

Nahon, Pierre, Nathalie Charnaux, V. Friand, et al.. (2008). The manganese superoxide dismutase Ala16Val dimorphism modulates iron accumulation in human hepatoma cells. Free Radical Biology and Medicine. 45(9). 1308–1317. 18 indexed citations

Sutton, Angéla, V. Friand, Thomas Chaigneau, et al.. (2007). Stromal Cell–Derived Factor-1/Chemokine (C-X-C Motif) Ligand 12 Stimulates Human Hepatoma Cell Growth, Migration, and Invasion. Molecular Cancer Research. 5(1). 21–33. 123 indexed citations

Sutton, Angéla, V. Friand, Thomas Chaigneau, et al.. (2007). [357] THE CHEMOKINE STROMAL CELL-DERIVED FACTOR-1(SDF-1)/CXCL12 STIMULATES HUMAN HEPATOMA CELL GROWTH, MIGRATION AND INVASION. Journal of Hepatology. 46. S139–S139. 2 indexed citations

Sutton, Angéla, V. Friand, Dulce Papy-García, et al.. (2007). Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells. Molecular Cancer Therapeutics. 6(11). 2948–2958. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact